PMA
P250050: Liverty™ TIPS Stent Graft
FDA PMA · SHUNT, PORTOSYSTEMIC, ENDOPROSTHESIS · Bard Peripheral Vascular, Inc.
Key facts
| PMA number | P250050 |
|---|---|
| Trade name | Liverty™ TIPS Stent Graft |
| Generic name | SHUNT, PORTOSYSTEMIC, ENDOPROSTHESIS |
| Applicant | Bard Peripheral Vascular, Inc. |
| Product code | MIR |
| Approval date | Sep 25, 2026 |
At a glance
- None Supplements
- Sep 25, 2026 Latest supplement decision
- No Withdrawn
- Yes Summary of safety and effectiveness on file
- None UDI device identifiers (GUDID)
- None MAUDE adverse event reports
- None Recall events
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA approvals
Premarket approval (PMA) is the FDA's most stringent review pathway, required for most Class III devices that support or sustain life or present a potentially unreasonable risk.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: